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Abstract: The temporomandibular joint pain, which occurs in the course of temporomandibular joint 
dysfunction, is one of the main clinical problems in the treatment of joint disc displacement.
T h e  a i m of the study was to evaluate changes in temporomandibular joints pain in treatment 
supporting disc displacement without reduction using intra-articular injection of hyaluronic acid and 
platelet-rich plasma.
M a t e r i a l  a n d  m e t h o d s: The study consisted of a  group of 60 patients, aged 35–49, who 
reported for treatment, because of pain in the preauricural area. The functional examination stated 
disk dicplacement without reduction, along with the accompanying pain of temporomandibular joints. 
Patients were treated between January 2015 and February 2017. They were divided into two groups of 
30 persons. The intraarticular injection of hyaluronic acid was administered in the I-test group, and the 
injection of platelet-rich plasma in the control group. This treatment was carried out parallel to the use 
of repositioning splits.
T h e  r e s u l t s: Analysis of regression of symptoms other than intensity of pain during the treatment, 
evaluated in this study shows a decrease of individual symptoms, but the results of the regression of pain 
between two groups did not differ statistically significantly, because “p” is bigger than 0.05.
C o n c l u s i o n: The results of the research show the clinical benefits of application of hyaluronic acid 
and plate rich plasma in the treatment of temporomandibular joint dysfunction.
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Introduction
The temporomandibular joint pain, which occurs in the course of temporomandibular 
joint dysfunction, is one of the main clinical problems in the treatment of joint disc 
displacement. Both forms of dysfunction, i.e. the disc displacement with and without 
reduction, indicate the significant progression of pathological changes within the 
musculoskeletal system [1–5].
The main cause of this kind of pathological changes is the increase in masseter 
muscles tension, i.e. occlusion paralysis (grinding, clenching or rattling), especially 
the upper lateral pterygoid muscles, whose trailers — in about 30% — are located 
directly to the joint disc within temporomandibular joints. Excessive muscle tension, 
i.e. muscle activity that exceeds the required physiological activity, causes frequent 
and prolonged pulling of the disc towards the front, resulting in tearing and damage 
to the ligament structure of the disk. This in turn becomes the cause of the inability 
to lead the disc back to the correct position on the jaw joint head [1–5].
Chronic stress and the influence of the limbic system, involving the emotional 
zone, on the pathological increase of temporomandibular joint muscles in the 
stomato gnathic system are mentioned as some causes responsible for the pathology 
of the temporomandibular joints. The configuration of the occlusion contacts of the 
individual teeth can be very detrimental to the lack of symmetry in the work of 
muscles located on both sides of the cranial face and thus uneven load on the TMJs. 
Craniofacial injuries are a rare cause of disk dislocation, but they should be considered 
in the subjective examination [6, 7].
Prosthetic treatment of disk displacement most often involves the use of occlusal 
splint (repositioning or relaxing in case of negative protrusion test) and supportive 
physiotherapeutic treatments such as manual therapy, laser biostimulation, or 
sonophoresis using analgesics [2, 5].
A recognized and frequently used method of orthopedic treatment of knee, jaw 
or elbow joints is intra-articular injection of hyaluronic acid and platelet-rich plasma 
(PRP). Exogenous visco-elastic acid is supplemented in the area of the compartment of 
superior joint (superior joint cavity), moisturizes the articular surfaces, improves the 
sliding of the joints, feeds them, as well as accelerates the healing process of damaged 
joints, especially the ligaments of the joint. Plate rich plasma is an autologous blood 
product that contains an increased platelet count in a  small volume of plasma. The 
concentration is usually 1,000,000 platelets per mm3 at blood pH of 6.5–6.7. The 
essence of PRP is the release of growth factor from granules of proteins, which greatly 
assist the regeneration of damaged tissues. Growth factors stimulate cell migration 
to the site of damage, their multiplication and differentiation, as well as blood vessel 
proliferation. The following processes are particularly important for healing; platelet-
derived growth factor, transforming, epithelial, insulin-like and vascular endothelial 
 Evaluation of remission of temporomandibular joints pain as a result of treatment… 59
growth factor. Adhesive molecules, polypeptides, enzymes, vitamins, oligoelements 
isolated from plasma play a key role in the activation and differentiation of stem cells. 
PRP is widely used in orthopedics, facial and maxillofacial surgery, periodontology, 
burn treatment, and more recently in sports and aesthetics medicine [8–16].
Consent of the Ethic Committee No KBET/125/L/2013 (1.07.2013).
The aim
The aim of the study was to evaluate changes in temporomandibular joints pain in 
treatment supporting disc displacement without reduction using intra-articular 
injection of hyaluronic acid and platelet-rich plasma.
Material and methods
The study material consisted of a  group of 60 patients aged 35–49, who reported 
for treatment to the Consulting Room of  temporomandibular joints dysfunction, 
Jagiellonian University Medical College in Krakow, because of pain in the preauricural 
area. The functional examination stated disk dicplacement without reduction, along 
with the accompanying pain of temporomandibular joints. Patients were treated 
between January 2015 and February 2017. They were divided into two groups of 
30 persons. The intraarticular injection of hyaluronic acid was administered in the I-test 
group, and the injection of platelet-rich plasma in the control group. This treatment 
was carried out parallel to the use of repositioning splits. In all cases, contraindications 
for the use of evaluated methods such as intraarticular injection (inflammatory skin 
disease) or peripheral blood plasma disease (blood disorders, thrombocytopenia, 
platelet dysfunction, fibrinogen deficiency) were excluded.
The criterion of inclusion in the study were: generally healthy patients, with full 
arched teeth, diagnosis of disk displacement without reduction, positive protrusion 
test, qualifying patients for use of repositioning splint.
Exclusion criteria from the study; occurrence of general illness, occurrence of disk 
displacement with reduction, patient’s will.
Patients who met the criteria for inclusion in the study were assigned alternately 
to the individual groups as soon as they applied for prosthetic treatment.
All patients were subjected to a  subjective and objective examination as well as 
specialized functional examination of the chewing organs. An important element of the 
examination was to determine the pain intensity of one or both temporomandibular 
joints (VAS + WNRS) and its radiation, as well as the evaluation of clinical parameters 
related to: the range and symmetry of the mandible movements, evaluation of the 
mandibular abduction tract, the results of the palpation of the musculoskeletal system 
of chewing organs, as well as analysis of additional symptoms.
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In selecting the type of occlusal device it was important to obtain the results of the 
protrusion test, i.e. the lowering of the mandible from the mandibular protuberance, 
and evaluation if at that moment the acoustic symptoms disappear. If the test was 
positive (disappearance of clicking), a repositioning splint was used; if the result was 
negative, then it was a relaxing splint. The recommended usage time of the splints in 
both groups was 21 hours per day.
The place of injection was determined in accordance with the rules for surgical 
treatment (Fig. 1) [10]. In group I, 1.5% hyaluronic acid was used for intra-
articular injection in the amount of 0.4 ml for each joint, whereas in group II blood 
was collected from patients with ulnar vein, using a  set of two tubes containing 
anticoagulant in the form of trisodium citrate (Fig. 2). Full blood was subjected to 
Fig. 1. The place of injection of hyaluronic acide and PRP in the area of temporomandibular joint 
dysfunction.
Fig. 2. “Closed” set for the patient’s blood collection.
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two spin cycles; in the first speed 2,400 rpm was used for 10 min, and the second 
spin was performed at 3,600 rpm for 10 min. Plate rich plasma was used directly 
after  centrifugation. After the injection, patients were informed about the proper 
treatment.
Intraarticular infusions were made three times according to the rules of antiseptics, 
in both temporomandibular joints, at two-weeks intervals. Intraarticular injections 
were performed without local anesthesia. Immediately after injection, the patients 
were monitored for 20 minutes to control their comfort. Functional examination of 
the stomatognatic system was performed twice, i.e. before treatment and 2 weeks after 
the third injection. Postoperative recommendations did not limit chewing activity 
after intervention.
In case of the measure giving the constant results, statistical analysis was based 
on the traditional methods of calculation: mean values, standard deviation, minimal 
values, maximal values, standard error of the mean, variance analysis for dependent 
variables and post-hoc Tukey test for dependent variables being the statistical 
significance measure.
To compare the dependencies between the results obtained in consecutive clinical 
tests, the non-parametric Friedman test, Kendall’s and Wilcoxon signed-rank test 
(comparing two related samples) were used. For statistical studies special computer 
software STATISTICA 2010 was used. A p value of less than 0.05 was accepted as 
statistically significant.
The results
The study involved 60 patients (43 women and 17 men, mean age 29.2 years, The 
study group — I includes 21 women and 9 men, and the control group — II contains 
of 22 women and 8 men. The symptoms reported by patients in group I and group II 
obtained during the medical interview and evaluation of clinical parameters have 
been included in the Table 1. Table 2 contains mean value of punctuation of score 
VAS + WNRS (pain of the temporomandibular joints) in group I  and II, collected 
during subsequent examinations.
The mean value of punctuation of score VAS + WNRS obtain in the first 
examination in group I  was 5,766 points, and in group II 5,533. These results did 
not differ statistically, what proves the homogeneity of the examined groups. In the 
second examination — after treatment the mean values of punctuation were 1,433 in 
the group I and 1,466 in group II. Te result are presented in the Table 2.
Analysis of regression of symptoms other than intensity of pain during the 
treatment, evaluated in this study shows a  decrease of individual symptoms, but 
the results of the regression of pain between two groups did not differ statistically 
significantly, because “p” is bigger than 0.05.
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Table 1. The symptoms reported by patients in group I  and group II obtained during the medical 
interview and evaluation of clinical parameters.
Symptoms of temporomandibular joint disorders
Group I Group II
Ex I Ex II Ex I Ex II
Spontaneous pain
single joint
acute 22  5 24 4
dull  4  1  2 0
bilaterally
acute  3  1  2 1
dull  1  1  2 0
Pain presence during mastication 18  4 22 2
Pain of the TMJs triggered by palpation 22  5 24 4
Pain associated with lower jaw movements 16  7 18 4
Masticatory muscle pain 24  7 25 8
Radiation of pain  8  2 10 3
Sounds, click in TMJs
single TMJ 19  1 20 3
bilaterally 11  2  9 1
Subjective feeling of increased tension in muscles 25  7 26 6
Constricted opening of the lower jaw  4  1  3 0
Constricted lateral mandibular movements  5  1  8 0
Mandibular deviation during opening 22  4 24 5
Difficulty on chewing 15 14 14 2
Occlusion parafunctions 30  5 30 8
„Closed ear” symptom on the affected TMJ side  2  0  4 2
Sudden hearing impairment  2  0  1 0
Tinnitus  1  0  2 0
Dizziness  2  1  2 1
Headaches 13  5 14 5
Pain in the neck  5  1  5 2
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Table 2. The intensity of the pain in temporomandibular joint dysfunction in punctuation of 
VAS + WNRS score.
Examination
Group
I examination II examination
 x– ± s
Min–Max 
Mediana
 x– ± s
Min–Max 
Mediana
I Group
5,766 ± 1,305
3–8
5.0
1,433 ± 1,04
0–4
1.5
II Group
5,533 ± 1,167
2–8
5.o
1,66 ± 1,188
0–3 
2.o
p
U Mann-Whitney
p = 0.5015 p = 0.05048
Discussion
Temporomandibular joints dysfunction of the stomatognatic system have a compound 
etiology and it is difficult to clearly identify the leading cause of their occurrence. 
The complexity of the problem is due to the condition of the temporomandibular 
joints and stomatognathic muscles. That why, treatment of dysfunction is not so 
easy task. Therefore, the searching a  new, supportive treatment methods is very 
valuable. Injections for orthopedic treatment have been rated for many years, and 
the healing and repairing properties of hyaluronic acid and platelet rich plasma are 
no longer of doubt. Injections of these preparations for temporomandibular joints 
are not commonly used, but few preliminary results in the available literature clearly 
raise hope for proven efficacy. Principles of treating dysfunctions of stomatognatic 
system include use; occlusal splints, botulinum toxin type A and physiotherapeutic 
procedures [9–17].
Comparative own studies show high efficacy of both formulations in joint pain 
remission and the results of VAS + WNRS scoring mean significant improvement in 
clinical parameters associated with functional assessment of stomatognathic system. 
These results are similar to those obtained by the Maheu et al., who emphasize not 
only the effectiveness of hyaluronic acid but also the safety of this viscosupposition. 
They emphasize that hyaluronic acid may exhibit greater efficacy in: less advanced 
pathological changes in the joints and in younger patients [18].
The European Society for Clinical and Economic Aspects of Osteoporosis and 
Osteoarthritis (ESCEO) treatment algorithm recommends intra-articular hyaluronic 
acide for advanced pharmacological managements of knee osteoarthritis. These 
authors also emphasize the superiority of acid injection over steroids administered 
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this way. The results of two meta-analyzes evaluating the efficacy of hyaluronic acid in 
intra-articular injection have revealed, beneficial effects on pain, function and patient 
global assesment at different postinjection time [18–22]. 
Cerza et al. [9] also compared the effectiveness of intra-articular injection of acid 
and plasma and their results indicate a high degree of efficacy of both test preparations. 
Also this therapeutic approach does not cause side effects such as inflammatory or 
pseudo septic reaction in the joints, what is very important. The precise mechanism 
of action of exogenous HA is unknown. However the proposed mechanism of the HA 
activity occurs in two stages; a mechanical and pharmacological stages. 
Mechanical stage is concern with synovial fluid is replaced by higher concentration 
of the of HA thereby improving viscosity and lubricating abilities of deplaned synovial 
fluid and maintains a boundary layer around nociceptors, what is a course of reducing 
pain induction. The pharmacological stages induces the biosynthesis of endogenous HA 
and extracellular matrix components which reduces proteoglycan loss in cartilage and 
apoptosis of chondrocytes. The authors emphasized that HA demonstrates a  greater 
effect beyond 12 weeks after injection with longer lasting benefits up to 6 month [9].
The clinical benefits of application of HA and PRP in the treatment of 
temporomandibular joint dysfunction are fact, but it is necessary to conduct further 
research in this area [16, 17, 19–23].
Summary
Searching for a new diagnostic and supporting methods of treatment of temporoman-
dibular joint dysfunction is still a current clinical problem. The complex etiology of the 
disease is determined by the need for individualized treatment, which is difficult for 
physicians. The current results of the research concern with hyaluronic acid and plate-
let-rich plasma in intra-articular injection in the region of temporomandibular joints 
are very important way of delivery of the such a  convenient substance and soon will 
be a  routine supporting method of prosthetic treatment of temporomandibular joints.
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